AI assistant
MACROGENICS INC — Director's Dealing 2014
May 30, 2014
34129_dirs_2014-05-30_b5136df7-7f6b-4243-8bc4-8c1298ae0fff.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2014-05-29
Reporting Person: Stein Kathryn E (Senior VP, Prd Dev & Reg Aff)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-05-29 | Common Stock | M | 10946 | $0.71 | Acquired | 54151 | Direct |
| 2014-05-29 | Common Stock | S | 10946 | $19.75 | Disposed | 43205 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-05-29 | Stock Option (right to buy) | $0.71 | M | 10653 | Disposed | 2015-12-15 | Common Stock (10653) | Direct |
| 2014-05-29 | Stock Option (right to buy) | $0.71 | M | 293 | Disposed | 2015-03-24 | Common Stock (293) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.50 to $19.91, inclusive. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
F2: The shares underlying the option became fully exercisable on December 15, 2009.
F3: The shares underlying the option became fully exercisable on March 24, 2009.